Evidence map›Paper›PMID 42856177›Full record

ArticlebioRxiv : the preprint server for biology2026

DHA deficiency drives neural oxidized-lipid stress and microglial activation.

Ryo Hagimori, Purnima Gogoi, Pawan K Shahi, Ryoya Ueno, Greg Barrett-Wilt, Michael Landowski, Kazuya Oikawa, Madison Tytanic, Richard S Brush, Jingyang Wei and 7 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ryo HagimoriDepartment of Medical Genetics, University of Wisconsin-Madison, Madison, WI, USA.
Purnima GogoiDepartment of Medical Genetics, University of Wisconsin-Madison, Madison, WI, USA.
Pawan K ShahiMcPherson Eye Research Institute, University of Wisconsin-Madison, Madison, WI, USA.
Ryoya UenoDepartment of Molecular Pathobiology, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
Greg Barrett-WiltMass Spectrometry Core Facility, Biotechnology Center, University of Wisconsin-Madison, Madison, WI, USA.
Michael LandowskiDepartment of Medical Genetics, University of Wisconsin-Madison, Madison, WI, USA.
Kazuya OikawaMcPherson Eye Research Institute, University of Wisconsin-Madison, Madison, WI, USA.
Madison TytanicDepartment of Ophthalmology and Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Richard S BrushDepartment of Ophthalmology and Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Jingyang WeiDepartment of Medical Genetics, University of Wisconsin-Madison, Madison, WI, USA.
Maya S GuerrieroDepartment of Medical Genetics, University of Wisconsin-Madison, Madison, WI, USA.
Gillian J McLellanMcPherson Eye Research Institute, University of Wisconsin-Madison, Madison, WI, USA.
Sakae IkedaDepartment of Medical Genetics, University of Wisconsin-Madison, Madison, WI, USA.
Martin-Paul AgbagaDepartment of Ophthalmology and Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Bikash R PattnaikMcPherson Eye Research Institute, University of Wisconsin-Madison, Madison, WI, USA.
Ken-Ichi YamadaDepartment of Molecular Pathobiology, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
Akihiro IkedaDepartment of Medical Genetics, University of Wisconsin-Madison, Madison, WI, USA.

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
UW Vision Research Core - Administrative CoreP30EY016665 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI ROBERT W NICKELLS · 2005 to 2026
$12.6M
Molecular Genetics of Age-Dependent Retinal DegenerationR01EY022086 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI AKIHIRO IKEDA · 2012 to 2026
$6.1M
Essential Role of Very Long Chain Fatty Acids in Retinal FunctionR01EY030513 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI AGBAGA, MARTIN-PAUL · 2019 to 2023
$1.8M
Automated Tissue MicroarrayerS10OD023526 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI MATKOWSKYJ, KRISTINA A. · 2018 to 2018
$184k
NCI NIH HHS P30 CA014520NEI NIH HHS P30 EY016665NEI NIH HHS R01 EY022086NEI NIH HHS R01 EY030513NIH HHS S10 OD023526
6 · The paper itself

Abstract

Despite the well-established importance of DHA in neural health, the mechanisms by which neural tissues respond to declining DHA availability and how this response contributes to aging remain poorly understood. Here, we show that chronic DHA deficiency triggers a neural-specific compensatory lipid-remodeling program with pathological consequences. DHA loss causes a neural-tissue-selective shift from DHA-containing phospholipids toward arachidonic and adrenic acid-containing ω-6 species, accompanied by an RPE-associated polyunsaturated fatty acid biosynthetic program. This remodeling expands the pool of oxidation-prone lipids, redirects lipid peroxidation toward ω-6-derived products, and increases oxidative damage. Dietary DHA restoration reversed lipid remodeling, oxidative stress, inflammation, and visual dysfunction, establishing DHA deficiency as a causal driver of these phenotypes in mice. We identified an APOE-dependent oxidized-lipid disposal pathway that transfers oxidized lipid cargo from the neural retina to subretinal microglia, limiting its retention within the neural retina and protecting against degeneration. However, with persistent lipid uptake, oxidized phospholipids accumulate in microglial lysosomes, with sustained galectin-3 activation. Galectin-3 deficiency preferentially protected against later-stage degeneration, indicating that prolonged lipid burden converts the initial clearance response into a pathogenic response. Physiologically aged retinas also showed a similar shift toward ω-6 lipid accumulation. These findings define an adaptive-to-maladaptive lipid-remodeling-microglia axis linking declining DHA availability to age-related neural dysfunction.

Identifiers

PMID42856177
PMCPMC13648334

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.